• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载体介导的蛋白质和肽稳定化。

Carrier mediated protein and peptide stabilization.

机构信息

Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Dr Hari Singh Gour University,Sagar-470 003, India.

出版信息

Drug Deliv. 2010 Nov;17(8):605-16. doi: 10.3109/10717544.2010.509359.

DOI:10.3109/10717544.2010.509359
PMID:20879837
Abstract

Proteins and peptides are complex macromolecules that are prone to change in their native structure during storage, which causes undesired side-effects after their administration. During past decades, bioactive carriers have played an important role in stabilization of proteins. Incorporation of the protein and peptides into a particulate carrier can protect it against degradation in vitro and in vivo, the release can be controlled,and it also offers possibilities for targeting. This review has focused on a wide range of bioactive carriers used in protein stabilization during long time storage. Bioactive carriers can protect the bioactives from degradation, resulting in increased bioavailability of protein.

摘要

蛋白质和肽类是复杂的大分子,在储存过程中容易改变其天然结构,从而导致给药后产生不良的副作用。在过去几十年中,生物活性载体在蛋白质的稳定化方面发挥了重要作用。将蛋白质和肽类掺入颗粒载体中可以保护其免受体外和体内的降解,还可以控制释放,并提供靶向的可能性。本综述重点介绍了在长时间储存过程中用于蛋白质稳定化的各种生物活性载体。生物活性载体可以保护生物活性物质不被降解,从而提高蛋白质的生物利用度。

相似文献

1
Carrier mediated protein and peptide stabilization.载体介导的蛋白质和肽稳定化。
Drug Deliv. 2010 Nov;17(8):605-16. doi: 10.3109/10717544.2010.509359.
2
Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.近年来药物制剂中稳定肽和蛋白质的趋势-辅料选择中的考虑因素。
Expert Opin Drug Deliv. 2009 Nov;6(11):1219-30. doi: 10.1517/17425240903199143.
3
Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery.用于设计含治疗性肽/蛋白质的可生物降解聚合物基微球以实现肠胃外控释给药的制造技术和辅料。
PDA J Pharm Sci Technol. 2008 Mar-Apr;62(2):125-54.
4
Drug delivery of oligonucleotides by peptides.通过肽进行寡核苷酸的药物递送。
Eur J Pharm Biopharm. 2004 Sep;58(2):237-51. doi: 10.1016/j.ejpb.2004.03.031.
5
Chitosan: a unique polysaccharide for drug delivery.壳聚糖:一种用于药物递送的独特多糖。
Drug Dev Ind Pharm. 1998 Nov;24(11):979-93. doi: 10.3109/03639049809089942.
6
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.脂质体、微粒和纳米粒在蛋白质和肽类药物传递中的最新进展。
Peptides. 2010 Jan;31(1):184-93. doi: 10.1016/j.peptides.2009.10.002. Epub 2009 Oct 9.
7
Thiomers: potential excipients for non-invasive peptide delivery systems.硫柳汞:用于非侵入性肽递送系统的潜在辅料。
Eur J Pharm Biopharm. 2004 Sep;58(2):253-63. doi: 10.1016/j.ejpb.2004.03.032.
8
Casein-based formulations as promising controlled release drug delivery systems.基于酪蛋白的配方作为有前途的控释药物传递系统。
J Control Release. 2011 Aug 10;153(3):206-16. doi: 10.1016/j.jconrel.2011.02.010. Epub 2011 Feb 19.
9
Carriers in the topical treatment of skin disease.皮肤病局部治疗中的载体。
Handb Exp Pharmacol. 2010(197):435-68. doi: 10.1007/978-3-642-00477-3_15.
10
Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.通过纳米包封和纳米生物缀合技术开发肽和蛋白质纳米治疗药物。
Peptides. 2011 Jan;32(1):173-87. doi: 10.1016/j.peptides.2010.10.003. Epub 2010 Oct 8.

引用本文的文献

1
Exploiting the potential of forming liquid crystals: development and performance of long-acting depots for peptide drug thymosin alpha 1 subcutaneous administration.利用形成液晶的潜力:用于肽类药物胸腺素α1皮下给药的长效贮库的开发与性能
Drug Deliv. 2025 Dec;32(1):2460708. doi: 10.1080/10717544.2025.2460708. Epub 2025 Mar 11.
2
BrSPR-20-P1 peptide isolated from sp. developed into liposomal hydrogel as a potential topical antimicrobial agent.从[具体物种]分离出的BrSPR-20-P1肽被开发成脂质体水凝胶,作为一种潜在的局部抗菌剂。
RSC Adv. 2024 Aug 28;14(37):27394-27411. doi: 10.1039/d4ra03722g. eCollection 2024 Aug 22.
3
Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications.
树枝状聚合物作为药物辅料:合成、性质、毒性及生物医学应用
Materials (Basel). 2019 Dec 21;13(1):65. doi: 10.3390/ma13010065.
4
Construction of Hyaluronic Tetrasaccharide Clusters Modified Polyamidoamine siRNA Delivery System.透明质酸四糖簇修饰的聚酰胺胺 siRNA 递送系统的构建
Nanomaterials (Basel). 2018 Jun 14;8(6):433. doi: 10.3390/nano8060433.
5
Carbon Nanomaterials: Efficacy and Safety for Nanomedicine.碳纳米材料:纳米医学中的功效与安全性
Materials (Basel). 2012 Feb 21;5(2):350-363. doi: 10.3390/ma5020350.
6
Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.用于胰岛素口服递送的含阳离子β-环糊精聚合物的耐酸海藻酸盐/三甲基壳聚糖纳米颗粒的研制
AAPS PharmSciTech. 2015 Aug;16(4):952-62. doi: 10.1208/s12249-014-0282-9. Epub 2015 Jan 22.
7
Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.胰岛素纳米粒的制备、统计优化及体外特性研究——壳聚糖季铵盐类芳香衍生物
AAPS PharmSciTech. 2011 Dec;12(4):1407-19. doi: 10.1208/s12249-011-9716-9. Epub 2011 Oct 27.
8
Post-production protein stability: trouble beyond the cell factory.后期蛋白质稳定性:细胞工厂之外的麻烦。
Microb Cell Fact. 2011 Aug 1;10:60. doi: 10.1186/1475-2859-10-60.